CompuGroup Medical SE & Co. KGaA Strategic Asset Allocation Index
CompuGroup Medical SE & Co. KGaA strategic asset allocation index. CompuGroup Medical SE & Co. KGaA (COP) has a Strategic Asset Allocation Index of 23.5% as of June 2023. Strategic assets (PP&E of €159.68 Million plus long-term investments of €-) total €159.68 Million, measured against net assets of €679.87 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of CompuGroup Medical SE & Co. KGaA to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CompuGroup Medical SE & Co. KGaA (2013–2022)
Strategic asset allocation index of CompuGroup Medical SE & Co. KGaA from 2013 to 2022. This chart shows how CompuGroup Medical SE & Co. KGaA's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 23.5%, representing strategic assets of €159.68 Million against net assets of €679.87 Million EUR. Check CompuGroup Medical SE & Co. KGaA (COP) tangible equity ratio to evaluate the tangible quality of the company's equity base.
CompuGroup Medical SE & Co. KGaA Strategic Asset Allocation Index by Year (2013–2022)
CompuGroup Medical SE & Co. KGaA strategic asset allocation index by year from 2013 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for CompuGroup Medical SE & Co. KGaA from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see COP stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.9% | €160.89 Million | €160.89 Million | €- | €673.82 Million | ▼ -1.9 pp |
| 2021 | 25.8% | €158.00 Million | €158.00 Million | €- | €612.28 Million | ▲ +4.5 pp |
| 2020 | 21.3% | €136.29 Million | €136.29 Million | €- | €638.94 Million | ▼ -30.5 pp |
| 2019 | 51.8% | €134.71 Million | €131.25 Million | €3.46 Million | €259.92 Million | ▲ +17.4 pp |
| 2018 | 34.5% | €94.09 Million | €83.65 Million | €10.44 Million | €273.00 Million | ▼ -5.2 pp |
| 2017 | 39.7% | €93.75 Million | €82.81 Million | €10.94 Million | €236.06 Million | ▲ +3.7 pp |
| 2016 | 36.0% | €78.75 Million | €73.85 Million | €4.90 Million | €218.65 Million | ▲ +2.9 pp |
| 2015 | 33.1% | €63.84 Million | €60.39 Million | €3.45 Million | €192.61 Million | ▼ -2.9 pp |
| 2014 | 36.0% | €63.23 Million | €62.05 Million | €1.18 Million | €175.63 Million | ▲ +0.4 pp |
| 2013 | 35.6% | €68.56 Million | €61.22 Million | €7.33 Million | €192.64 Million | — |